Dose optimization, dietary adjustments, and exercise modifications typically produce better results than adding unvalidated combination protocols
The FDA's Pharmacy Compounding Advisory Committee reviewed BPC-157 on 23 July 2026 for possible inclusion on the 503A bulks list
Learn how peptides may complement regenerative therapies such as PRP, stem cell treatments, and rehabilitation programs while helping active individuals maintain recovery, mobility, and performance as they age
We typically include vitamin D, B12, folate, iron studies including ferritin, magnesium (often RBC magnesium for better accuracy), zinc, copper, omega-3 index, and any additional markers indicated by your history or symptoms
Marketing Claims to Avoid Don't claim BPC-157 heals, cures, or treats anything: not injuries, tissue repair, gut problems, or pain